Citigroup Inc. (C: Quote) is rising over 2 percent to $27.20. The company's second quarter profit declined from the previous year period, although earnings per share were above Wall Street view. Total revenues for the quarter fell 10 percent and were below the consensus estimate.
Par Pharmaceutical Companies Inc. (PRX: Quote) is rising over 36 percent to $49.90. The company has agreed to be acquired by an affiliate of TPG in a transaction with an equity value of $1.9 billion or $50.00 per share.
Zogenix, Inc. (ZGNX: Quote) is up more than 8 percent to $2.39. The company announced that the FDA has accepted for review the New Drug Application for Zohydro ER (hydrocodone bitartrate extended-release capsules).
Human Genome Sciences (HGSI: Quote) is gaining over 3 percent to $14.03. There were reports that GlaxoSmithKline plc (GSK: Quote,GSK.L) is in friendly talks to acquire the company for more than $2.6 billion.
Trading in shares of Woodward, Inc. (WWD: Quote) was halted. The company announced third quarter preliminary results, which were sharply below Wall Street view. The company noted that its Aerospace segment sales and earnings came in below expectations for the quarter. The company also lowered its fiscal year forecast, in light of macroeconomic uncertainty and the issues identified in the third quarter.
| || |
| To receive FREE breaking news email alerts for Citigroup Inc. and others in your portfolio|
by RTT Staff Writer
For comments and feedback: email@example.com